390 related articles for article (PubMed ID: 15198686)
1. Lymphatics at the crossroads of angiogenesis and lymphangiogenesis.
Scavelli C; Weber E; Aglianò M; Cirulli T; Nico B; Vacca A; Ribatti D
J Anat; 2004 Jun; 204(6):433-49. PubMed ID: 15198686
[TBL] [Abstract][Full Text] [Related]
2. [Lymphangiogenesis in cancerous tumours].
Bednarek W; Wertel I; Kotarski J
Ginekol Pol; 2008 Sep; 79(9):625-9. PubMed ID: 18939514
[TBL] [Abstract][Full Text] [Related]
3. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
4. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
Sun L; Duan J; Jiang Y; Wang L; Huang N; Lin L; Liao Y; Liao W
Cancer Lett; 2015 Feb; 357(1):242-253. PubMed ID: 25444928
[TBL] [Abstract][Full Text] [Related]
5. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells.
Garrafa E; Caprara V; Di Castro V; Rosanò L; Bagnato A; Spinella F
Life Sci; 2012 Oct; 91(13-14):638-43. PubMed ID: 22552325
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
8. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
9. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
10. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors.
Kärpänen T; Heckman CA; Keskitalo S; Jeltsch M; Ollila H; Neufeld G; Tamagnone L; Alitalo K
FASEB J; 2006 Jul; 20(9):1462-72. PubMed ID: 16816121
[TBL] [Abstract][Full Text] [Related]
12. VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.
Koch M; Dettori D; Van Nuffelen A; Souffreau J; Marconcini L; Wallays G; Moons L; Bruyère F; Oliviero S; Noel A; Foidart JM; Carmeliet P; Dewerchin M
J Pathol; 2009 Nov; 219(3):356-64. PubMed ID: 19718705
[TBL] [Abstract][Full Text] [Related]
13. Lymphangiogenesis and tumour metastasis.
Tille JC; Nisato R; Pepper MS
Novartis Found Symp; 2004; 256():112-31; discussion 132-6, 259-69. PubMed ID: 15027486
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
[TBL] [Abstract][Full Text] [Related]
15. VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.
Secker GA; Harvey NL
Dev Dyn; 2015 Mar; 244(3):323-31. PubMed ID: 25399804
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-C accelerates diabetic wound healing.
Saaristo A; Tammela T; Farkkilā A; Kärkkäinen M; Suominen E; Yla-Herttuala S; Alitalo K
Am J Pathol; 2006 Sep; 169(3):1080-7. PubMed ID: 16936280
[TBL] [Abstract][Full Text] [Related]
18. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
[TBL] [Abstract][Full Text] [Related]
19. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.
Hong YK; Lange-Asschenfeldt B; Velasco P; Hirakawa S; Kunstfeld R; Brown LF; Bohlen P; Senger DR; Detmar M
FASEB J; 2004 Jul; 18(10):1111-3. PubMed ID: 15132990
[TBL] [Abstract][Full Text] [Related]
20. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
